Search research articles
Contact Us
Filters
Showing results (21-30 of 208) with videos related to
Page
of 21
Sort By:
Journal of Mass Spectrometry : JMS
|
August 9, 2007
Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study
M Wade Calcutt, Wooin Lee, Igor Puzanov, et al.
Frontiers in Immunology
|
March 11, 2026
Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management
Bianca Arianna Facchini, Benjamin Switzer, Marc S Ernstoff, et al.
American Journal of Cancer Research
|
November 12, 2021
Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy
Fengzhi Li, Christos Fountzilas, Igor Puzanov, et al.
Current Oncology Reports
|
May 10, 2020
COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain, Yara Abdou, Abhay Singh, et al.
Oncotargets and Therapy
|
March 4, 2017
<i>BRAF</i><sup>V600</sup> mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study
Allen L Cohn, Bann-Mo Day, Sarang Abhyankar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
July 23, 2024
Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns
Joseph Elijah, Igor Puzanov, Benjamin Cresanti, et al.
Communications Medicine
|
June 13, 2024
Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers
Badri Karthikeyan, Sunitha Shyam Sunder, Igor Puzanov, et al.
Oncoimmunology
|
December 22, 2016
Responses to immune checkpoint inhibitors in nonagenarians
Romany A N Johnpulle, Robert M Conry, Jeffrey A Sosman, et al.
Essays in Biochemistry
|
July 22, 2022
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness
Xiaozhuo Liu, Wen Jess Li, Igor Puzanov, et al.
British Journal of Clinical Pharmacology
|
September 3, 2017
Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours
Masaya Tachibana, Kyriakos P Papadopoulos, John H Strickler, et al.
Page
of 21
Search research articles
Search
Showing results (21-30 of 208) with videos related to
Sort By:
Page
of 21
Journal of Mass Spectrometry : JMS
|
August 9, 2007
Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study
M Wade Calcutt, Wooin Lee, Igor Puzanov, et al.
Frontiers in Immunology
|
March 11, 2026
Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management
Bianca Arianna Facchini, Benjamin Switzer, Marc S Ernstoff, et al.
American Journal of Cancer Research
|
November 12, 2021
Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy
Fengzhi Li, Christos Fountzilas, Igor Puzanov, et al.
Current Oncology Reports
|
May 10, 2020
COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain, Yara Abdou, Abhay Singh, et al.
Oncotargets and Therapy
|
March 4, 2017
<i>BRAF</i><sup>V600</sup> mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study
Allen L Cohn, Bann-Mo Day, Sarang Abhyankar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
July 23, 2024
Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns
Joseph Elijah, Igor Puzanov, Benjamin Cresanti, et al.
Communications Medicine
|
June 13, 2024
Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers
Badri Karthikeyan, Sunitha Shyam Sunder, Igor Puzanov, et al.
Oncoimmunology
|
December 22, 2016
Responses to immune checkpoint inhibitors in nonagenarians
Romany A N Johnpulle, Robert M Conry, Jeffrey A Sosman, et al.
Essays in Biochemistry
|
July 22, 2022
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness
Xiaozhuo Liu, Wen Jess Li, Igor Puzanov, et al.
British Journal of Clinical Pharmacology
|
September 3, 2017
Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours
Masaya Tachibana, Kyriakos P Papadopoulos, John H Strickler, et al.
Page
of 21